Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Strong Sales Boost Beckman Coulter s Q1 Profit; R&D Static

NEW YORK, April 29 - Beckman Coulter today said first-quarter profit rose nearly 20 percent as sales improved for its robotic automation and genetic analysis tools.

Sales for the period ended March 31 climbed 3.2 percent to $446.7 million as sales increased in the Americas and Europe. Sales declined in Asia, however.

Net earnings were $28 million, or $.43 per share, compared with $23.4 million, or $.37 per share, one year ago, Beckman said.  


The company added that second-quarter sales will grow 6 percent.

R&D spending, meanwhile, was static year over year at about $42 million. However, Beckman's cash and cash equivalents as of March 31 were $35 million, off slightly from the $36 million it posted one year ago, the firm said.

 

For more information, readers may click here.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.